Immediate and short-term efficacy of suicide-targeted interventions in suicidal individuals: a systematic review

A Lengvenyte, E Olié, R Strumila… - The World Journal of …, 2021 - Taylor & Francis
Objectives To address the extreme suicide risk period following a suicidal crisis, we aimed to
assess the current evidence for specific healthcare system-based interventions on suicide …

Endogenous opiates and behavior: 2018

RJ Bodnar - Peptides, 2020 - Elsevier
This paper is the forty-first consecutive installment of the annual anthological review of
research concerning the endogenous opioid system, summarizing articles published during …

Mu-opioid receptor (MOR) biased agonists induce biphasic dose-dependent hyperalgesia and analgesia, and hyperalgesic priming in the rat

D Araldi, LF Ferrari, JD Levine - Neuroscience, 2018 - Elsevier
Stimulation of the mu-opioid receptor (MOR) on nociceptors with fentanyl can produce
hyperalgesia (opioid-induced hyperalgesia, OIH) and hyperalgesic priming, a model of …

[HTML][HTML] Novel hybrid compounds, opioid agonist+ melanocortin 4 receptor antagonist, as efficient analgesics in mouse chronic constriction injury model of …

J Starnowska-Sokół, A Piotrowska, J Bogacka… - …, 2020 - Elsevier
When the nerve tissue is injured, endogenous agonist of melanocortin type 4 (MC4)
receptor, α-MSH, exerts tonic pronociceptive action in the central nervous system …

PACTS-assisted thermal proteome profiling for use in identifying peptide-interacting proteins

T Zhao, J Tian, X Wang, Y Hao, M Xu, Y Zhao… - Analytical …, 2022 - ACS Publications
Bioactive peptides play important roles in various biological processes. However, the
traditional methods for profiling the peptide-interacting proteins require modifications to the …

Circular RNA expression profile in the spinal cord of morphine tolerated rats and screen of putative key circRNAs

Y Weng, J Wu, L Li, J Shao, Z Li, M Deng, W Zou - Molecular Brain, 2019 - Springer
Morphine tolerance developed after repeated or continuous morphine treatment is a global
health concern hindering the control of chronic pain. In our previous research, we have …

Buprenorphine Pharmacodynamics: A Bridge to Understanding Buprenorphine Clinical Benefits

M Davis - Drugs, 2025 - Springer
Buprenorphine is an agonist at the mu opioid receptor (MOR) and antagonist at the kappa
(KOR) and delta (DOR) receptors and a nociceptin receptor (NOR) ligand. Buprenorphine …